Back

High Lp(a) levels are a potential risk factor for aortic valve interventions in patients with bicuspid aortic valve

25 April 2024 (13:15 - 13:25)
Organised by: Logo
Congress Presentation Part of: Lipid management in different populations Lipids Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Associate Professor Reza Arsanjani

Mayo Clinic, Scottsdale (United States of America)

3 More presentations in this session

Presentation thumbnail
Quiz presentation
Doctor S. Gati (London, GB) Professor V. Vassiliou (Norwich, GB)
Slides Video
Presentation thumbnail
Lipid-lowering treatment pattern in chronic coronary syndrome - lower proportion of treatment observed among women during 3 years of follow-up
Doctor N. Johnston (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Increased low-density lipoprotein cholesterol predict the risk of progressive structural but not functional cardiac damage in youth: a 7-year follow-up study
Doctor A. Agbaje (Kuopio, FI)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid management in different populations

The Event

Event poster

ESC Preventive Cardiology 2024

25 April 2024 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Lp(a) and aortic stenosis: epidemiology
thumbnail
Congress Session
Lp(a) and aortic stenosis
thumbnail
Congress Presentation
Lp(a) as a treatment target for aortic stenosis?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources